24/7 Market News Snapshot 15 April, 2025 – PLUS THERAPEUTICS, Inc. Common Stock (NASDAQ:PSTV)

April 15, 2025

DENVER, Colo., 15 April, 2025 (www.247marketnews.com) – (Nasdaq:PSTV) are discussed in this article.
Plus Therapeutics, Inc. (Nasdaq:PSTV), a pioneering developer of targeted radiotherapeutics for central nervous system (CNS) cancers, recently exhibited a notable uptick in pre-market trading, with shares priced at $0.693, an increase of 8.37% from the previous close of $0.639. A considerable trading volume of 12.21 million shares reflects heightened investor interest and the potential for further accumulation of stock. Technical analysis suggests a promising upward trend, as the stock has surpassed key resistance levels, indicating potential buying momentum that warrants close monitoring amid prevailing market conditions.

In parallel, Plus Therapeutics announced the forthcoming online release of significant new data concerning its lead compound, REYOBIQ™ (rhenium Re186 obisbemeda), which will be presented at the Nuclear Medicine and Neurooncology Conference scheduled for May 9-10, 2025. The findings, drawn from the completed Phase 1 ReSPECT-LM dose escalation trial, demonstrate a dose-dependent increase in absorbed radiation, achieving a remarkable 253Gy in Cohort 5. Among 16 patients evaluated, 31% displayed a partial response, while a substantial 75% reported clinical benefits, including stable disease.

Marc H. Hedrick, M.D., President and CEO of Plus Therapeutics, highlighted the significance of these results, asserting that the data strengthens the company’s belief in REYOBIQ’s potential to meet the needs of patients with Leptomeningeal Metastases—a severe complication in cancer care with few effective treatment options available. The targeted approach of REYOBIQ aims not only to improve treatment responses but also minimizes collateral damage to healthy tissues, marking a crucial advancement in CNS cancer therapies. This progress underscores Plus Therapeutics’ dedication to enhancing patient outcomes in a field where alternatives remain scarce.

Related news for (PSTV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.